psychedelic

The Uncertain Path Forward for Psychedelic Medicine

by
The Uncertain Path Forward for Psychedelic Medicine

But psychedelic compounds are tricky to test in this way because their psychedelic effects are so recognizable to those who take them. In the Lykos trials, around 90 percent of the participants were able to correctly guess whether they received MDMA or a placebo, effectively “unblinding” the study. If participants knew they received MDMA, they … Read more

The FDA Just Rejected a Bid for MDMA to Treat PTSD

by
The FDA Just Rejected a Bid for MDMA to Treat PTSD

The US Food and Drug Administration has rejected a first-of-its-kind proposal to use the psychedelic drug MDMA, also known as ecstasy or Molly, as a treatment for post-traumatic stress disorder. Drugmaker Lykos Therapeutics had asked the FDA to approve the drug in combination with talk therapy. The company said Friday that the regulatory agency has … Read more